Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.001B Est
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.001 billion estimate.
Astrana Health kept its sales target the same, saying it expects to make between $3.8 billion and $4.1 billion next year. This range is a bit lower than what some people were guessing, so watch whether the company can hit its own numbers or surprise people.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.